October 19, 2021
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, October 2021

A focus on the Fall 2021 ECOG-ACRIN Group Meeting; remembering two major leaders in oncology; studying smoking cessation in patients with cancer
October 19, 2021

Virtual Fall 2021 Group Meeting: Tips and Highlights

Though we had hoped to meet in person this fall, the pandemic has kept us on our toes—and in front of our screens.
October 19, 2021
Young investigator headshots

Meet the 2021 Young Investigator Symposium Presenters

Eight early-career investigators will present their work; two will be selected to receive awards of distinction
October 19, 2021

Remembering Martin “Mac” Cheever, MD

In September, the field of immunotherapy lost one of its pioneers
October 19, 2021

Remembering Franco M. Muggia, MD

In September, the field of oncology lost a worldwide ovarian therapeutics leader and unparalleled mentor to generations
October 19, 2021
Man on couch on laptop

Trial Spotlight: Elyse Park on EAQ171CD – the Smoke-Free Support Study 2.0

This phase II randomized controlled trial is comparing the effectiveness of two different approaches to help recently diagnosed patients with cancer become smoke-free
October 19, 2021
News in Brief

News in Brief, October 2021

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
September 30, 2021
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, September 2021

A focus on leukemia trials; an update regarding advanced practice providers; two important topics related to patient communication
September 30, 2021

Now Enrolling: Phase II of EA9152 for Acute Lymphoblastic Leukemia

This phase Ib/II study is testing the effects and safety of venetoclax in combination with liposomal vincristinein patients with B-ALL or T-ALL
September 30, 2021

NCI-MATCH Eliminates the Need for a Formal Referral Letter from the Laboratories

Removing one of several steps will help speed the process for identifying patients who may be eligible to enroll for treatment in NCI-MATCH
September 30, 2021
Jill Feldman and Kristin Ito Headshots

A New Guide Encourages the Use of Language that is Respectful of Patients, Free of Stigma, Inclusive, and Equitable

A new Language Guide provides guidelines on best practices with common phrases to use during presentations at medical conferences and within submitted abstracts
September 30, 2021
Envelope and paper

Should Participants Know the Arm to Which They Were Assigned in a Randomized Clinical Trial?

The ethical imperative is that we must not treat the patient as a mere subject but as a participant partner, who therefore has rights to information about the trial to which they contributed